Wordt geladen...
Risperidone long-acting injection in the treatment of schizophrenia: 24-month results from the electronic Schizophrenia Treatment Adherence Registry in Canada
OBJECTIVE: To assess outcomes over 24 months in Canadian patients with schizophrenia initiated on risperidone long-acting injection (RLAI) and participating in the electronic Schizophrenia Treatment Adherence Registry (e-STAR). MATERIALS AND METHODS: Patients with schizophrenia or schizoaffective di...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2014
|
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3942298/ https://ncbi.nlm.nih.gov/pubmed/24600227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S54740 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|